To understand the subcellular localization of the vitamin D receptor (VDR) and to measure VDR content in single cells, we recently developed a fluorescent labeled ligand, 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene (BODIPY)-calcitriol. This tagged hormone has intact biological activity, high affinity and specific binding to the receptor, and enhanced fluorescent emission upon receptor binding. Using BODIPY-calcitriol, here we monitored the subcellular distribution of VDR in living cultured cells by microscopy. Time course studies showed that an equilibrium between the cytoplasmic and nuclear hormone binding developed within 5 min and was maintained thereafter. We found a substantial proportion of VDR residing in the cytoplasm, colocalized with endoplasmic reticulum, the Golgi complex, and microtubules. Confocal microscopy clarified the presence of VDR within discrete regions of the nucleus and along the nuclear envelope. There was no VDR in the plasma membrane. Low affinity BODIPY-calcitriol binding sites were in the mitochondria. Mutations in the VDR gene selectively and specifically altered BODIPYcalcitriol distribution. Defects in the hormone binding region of VDR prevented both nuclear and cytoplasmic hormone binding. Defects in the DNA binding region decreased the nuclear retention of VDR and prevented localization to nuclear foci. These results with BODIPYcalcitriol reveal cytoplasmic VDR localization in living cells and open the possibility of studying the three-dimensional architecture of intranuclear target sites.
The vitamin D receptor (VDR)1 belongs to the v-erb-A superfamily of ligand activated transcription factors. The hormonal forms of vitamin D and other steroid hormones act through their receptors to regulate the transcription of target genes and thus modulate a variety of cell functions. These hormones also exert rapid, so-called "nongenomic" actions that take place outside the nucleus. Over the last 30 years we learned many aspects of steroid receptor activation, but the subcellular distribution of the receptors remained controversial. The use of radioligands led to the classical model for steroid receptor activation, which placed the receptors in the cytoplasm (1). Later, antibodies were raised against steroid receptors, and immunocytology suggested that unactivated steroid receptors reside exclusively in the nucleus (2). In the past few years, evidence has accumulated showing that glucocorticoid, mineralocorticoid, and androgen receptors reside both in the cytoplasm and in the nucleus. Nevertheless, the consensus has remained unchanged for the nuclear localization of estrogen receptors, thyroid hormone receptors, and VDR (3). Several studies with immunocytology on aldehyde-fixed cells showed that VDR resides exclusively in the nucleus (4). However, using microwave fixation, we found a significant portion of VDR in the cytoplasm (5). Since then, cytoplasmic VDR has been found by others (6 -10), but the existence of cytoplasmic VDR is still not generally accepted (11,12).While the role of nucle...